The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase-Reference-Cited by-同舟云学术

The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase

Published:2019-08 Issue:4 Volume:178 Page:807-819.e21
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Sanghvi Viraj R.,Leibold Josef,Mina Marco,Mohan Prathibha,Berishaj Marjan,Li Zhuoning,Miele Matthew M.,Lailler Nathalie,Zhao Chunying,de Stanchina Elisa,Viale Agnes,Akkari Leila,Lowe Scott W.,Ciriello Giovanni,Hendrickson Ronald C.,Wendel Hans-Guido

Funder

Shulamit Katzman

MSKCC

NIH

Howard Hughes Medical Institute

the Giorgi-Cavaglieri Foundation

Lymphoma Research Foundation

Commonwealth Foundation for Cancer Research

Starr Cancer Consortium

Geoffrey Beene Cancer Research Center

Leukemia and Lymphoma Society

Leukemia Lymphoma Society

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference71 articles.

1. Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture;Abdel-Wahab;J. Endocrinol.,1997

2. Review: Glycation of human serum albumin;Anguizola;Clin chim acta,2013

3. Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer;Arbour;Clin cancer res,2018

4. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters;Bai;Drug Metab. Rev.,2016

5. The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma;Banito;Cancer cell,2018

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib and SIAIS361034, a novel PROTAC degrader of BCL-xL, display synergistic antitumor effects on hepatocellular carcinoma with minimal hepatotoxicity;Biochemical Pharmacology;2024-09

2. SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma;2024-08-08

3. The molecular basis of Human FN3K mediated phosphorylation of glycated substrate;2024-08-05

4. A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer’s Disease;Nano Letters;2024-08-01

5. Nrf2 mediated signaling axis in heart failure: Potential pharmacological receptor;Pharmacological Research;2024-08